市場調查報告書
商品編碼
1380434
2023-2030 年全球自動顯微鏡市場Global Automated Microscopy Market 2023-2030 |
全球自動化顯微鏡市場預計在預測期內(2023-2030)將以 7.5% 的CAGR成長。市場的成長歸功於掃描電子顯微鏡(SEM)技術的發展。自動化功能的發展,包括「簡單SEM」攝影、剪輯和即時元素分析,顯示掃描電子顯微鏡技術不斷進步。為研究和應用尋求更有效、更方便的工具的使用者被上述增強功能所吸引。例如,2022 年 1 月,JEOL 推出了具有「簡單 SEM」自動化和即時元素和 3D 分析功能的新型掃描電子顯微鏡。新型掃描電子顯微鏡具有提高生產力的自動化功能,例如「簡單 SEM」自動成像、自動拼接(影像和 EDS 圖)以及即時 EDS 分析(光譜和圖)。
全球自動化顯微鏡市場按產品、應用和最終用戶進行細分。依產品,市場細分為倒置顯微鏡、螢光顯微鏡、電子顯微鏡、掃描電子顯微鏡、光學顯微鏡等。根據應用,市場分為生命科學和生物醫學研究半導體等。此外,根據最終用戶,市場細分為醫院和醫療機構、學術和研究機構、臨床和診斷實驗室等。在該產品中,光學顯微鏡子類別預計將佔據很大一部分市場佔有率。與電子顯微鏡或掃描探針顯微鏡等其他顯微鏡方法相比,光學顯微鏡更容易使用且更具成本效益。
在最終用戶中,臨床和診斷實驗室細分市場預計將在全球自動顯微鏡市場中佔據相當大的佔有率。該細分市場的成長歸因於對診斷和臨床實驗室的需求不斷成長。為了幫助疾病診斷、患者治療和監測,臨床和診斷實驗室進行各種測試。 UNIQO 160主要滿足這些實驗室在自體免疫疾病診斷上的需求。例如,2023年6月,Revvity Inc.推出了UNIQO 160(CE-IVDR),這是一種用於自體免疫疾病診斷的自動化間接免疫螢光測試(IIFT)系統。整合解決方案提高了整個 IIFT 程序的效率,包括樣品製備、孵育、清洗和載玻片安裝以及影像擷取和分析。
全球自動化顯微鏡市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(英國、義大利、西班牙、德國、法國和歐洲其他地區)、亞太地區(印度、中國、日本) 、韓國和亞洲其他地區)以及世界其他地區(中東和非洲以及拉丁美洲)。其中,由於亞太地區有利的經濟環境和豐富的潛在客戶,預計該地區將在全球市場中佔據顯著佔有率。此外,許多重要的自動化顯微鏡企業正在擴大其業務,預計這將進一步加速市場擴張。
在所有地區中,預計北美在預測期內將以相當大的CAGR成長。區域成長歸因於該地區結核病 (TB) 診斷和治療的增加。作為一個重大的全球健康問題,結核病需要及時發現和治療,這需要有效的診斷技術。 μ-Scan 2.0 增強的敏感度和特異度可改善結核病的控制和管理。據美國國立衛生研究院(NIH.gov)稱,2022年5月,μ-Scan 2.0自動化系統在一項涉及1726張塗片的多中心、雙盲試驗中進行了評估。此系統的準確率為95.7%,敏感性為87.7%(57/65),特異性為96.0%(1,594/1,661)。盛行率為 8.2% 時,陰性預測值為 97.8%。 μ-Scan 2.0自動化系統被發現比手動塗片顯微鏡具有更高的結核塗片靈敏度和實驗室效率,並為結核病診斷和控制提供了具有成本效益的解決方案。它還可以透過網路連線遠端使用,適合醫療資源有限的地區。
服務全球自動顯微鏡市場的主要公司包括:日立高新技術公司、Holmoc Opto-Mechatronics Ltd.、JEOL Ltd.、Keyence Corp.、Leica Microsystems 等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布),為市場成長做出了巨大貢獻,以保持市場競爭力。例如,2023 年 5 月,HORIBA 推出了 EasyImage,這是一種用於拉曼顯微鏡的新型成像工具。 EasyImage 旨在幫助新用戶快速產生可發布的結果。它提供了使用拉曼光譜生成化學圖像、聚焦和選擇感興趣區域、最佳化成像參數、選擇光譜指紋、預覽測量結果和收集高品質化學圖像的 5 個關鍵步驟的指導。
Title: Global Automated Microscopy Market Size, Share & Trends Analysis Report by Product (Inverted Microscope, Fluorescence Microscope, Electron Microscope, Scanning Electron Microscopes (SEM), Optical Microscope, and Others), by Application (Life Sciences and Biomedical Research, Semiconductors, and Others), and by End-User (Hospitals and Healthcare Facilities, Academic and Research Institutions, Clinical and Diagnostic Laboratories, and Others)Forecast Period (2023-2030).
The global automated microscopy market is anticipated to grow at a CAGR of 7.5% during the Forecast Period (2023-2030). The market's growth is attributed to the development in scanning electron microscope (SEM) technology. The development of automation features, including "Simple SEM" photography, montaging, and live elemental analysis, indicates that scanning electron microscopy technology constantly progressing. Users seeking more effective and convenient tools for their research and applications are attracted by the aforementioned enhancements. For instance, in January 2022, JEOL Introduced new Scanning Electron Microscope with "Simple SEM" Automation and Live Elemental And 3D Analysis. The new scanning electron microscope has productivity-enhancing automation, such as "Simple SEM" automated imaging, automated montaging (both image and EDS map),and live EDS analysis (spectrum and map).
The global automated microscopy market is segmented on the products, applications, and end-users. Based on the product, the market is sub-segmented into inverted microscope, fluorescence microscope, electron microscope, scanning electron microscopes, optical microscope, and others. Based on the applications, the market is sub-segmented into life sciences and biomedical research semiconductors, and others. Furthermore, based on end-user, the market is sub-segmented into hospitals and healthcare facilities, academic and research institutions, clinical and diagnostic laboratories, and others. Among the product, the optical microscope sub-category is expected to capture a significant portion of the market share. Optical microscopes are more accessible and cost-effective compared to other microscopy methods such as electron microscopy or scanning probe microscopy.
Among the end-user, the clinical and diagnostic laboratories sub-segment is expected to hold a considerable share of the global Automated Microscopy market. The segmental growth is attributed to growing demand for diagnostic and clinical laboratories. In order to help with disease diagnosis, patient treatment, and monitoring, clinical and diagnostic laboratories perform a variety of tests. The UNIQO 160 primarily addresses the needs of these labs with regard to the diagnosis of autoimmune diseases. For instance, in June 2023, Revvity Inc. launched the UNIQO 160 (CE-IVDR), an automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics. The efficiency of the entire IIFT procedure that includes sample preparation, incubation, washing and mounting of slides, in addition to image acquisition and analysis is increased by the integrated solution.
The global automated microscopy market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market globally, owing to the favorable economic environment and abundance of potential clients in the region. Further, number of significant automated microscopy businesses are expanding their operations, which is further anticipated to accelerate market expansion.
Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising tuberculosis (TB) diagnosis and treatment across the region. As a significant global health concern, TB requires prompt detection and treatment, that prompts for effective diagnostic techniques. The enhanced sensitivity and specificity of the μ-Scan 2.0 lead to improved control and management of tuberculosis. According to the National Institute of Health (NIH.gov), in May 2022, the μ-Scan 2.0 automation system was evaluated in a multi-center, double-blind trial involving 1726 smears. The accuracy of the system was 95.7%, the sensitivity was 87.7% (57/65), and the specificity was 96.0% (1,594/1,661). The negative predictive value was 97.8% at a prevalence of 8.2%. The μ-Scan 2.0 automation system was found to have higher TB smear sensitivity and laboratory efficiency than manual smear microscopy, and provides a cost effective solution for TB diagnosis and control. It can also be used remotely through an internet connection, making it suitable for areas with limited medical resources.
The major companies serving the global automated microscopy market include: Hitachi High-Tech Corp., Holmarc Opto-Mechatronics Ltd., JEOL Ltd., Keyence Corp., Leica Microsystems, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in May 2023, HORIBA launched EasyImage, a new imaging tool for Raman microscopy. EasyImage is designed to help new users to quickly generate publication-ready results. It provides guidance on the 5 key steps for generating chemical images using Raman spectroscopy, focusing and selecting an area of interest, optimizing imaging parameters, selecting a spectral fingerprint, previewing measurements, and collecting a high-quality chemical image.